Fortis Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend and Momentum Analysis

Recent technical assessments reveal that Fortis Healthcare's price momentum has evolved from a neutral sideways pattern to a mildly bullish trajectory. The daily moving averages have turned mildly bullish, indicating that short-term price action is gaining upward traction. This is supported by the Bollinger Bands on both weekly and monthly charts, which are mildly bullish, suggesting that volatility is expanding in favour of upward price movement.

However, the momentum indicators present a mixed picture. The MACD (Moving Average Convergence Divergence) remains mildly bearish on both weekly and monthly timeframes, signalling that the underlying momentum is yet to fully confirm a strong bullish reversal. Similarly, the KST (Know Sure Thing) indicator is mildly bearish on weekly and monthly charts, reinforcing the notion of cautious optimism rather than outright bullishness.

The Relative Strength Index (RSI) on weekly and monthly scales currently shows no definitive signal, hovering in a neutral zone that neither indicates overbought nor oversold conditions. This suggests that the stock price has room to move in either direction, depending on forthcoming market catalysts.

Price Action and Moving Averages

Fortis Healthcare closed at ₹935.00, up 1.02% from the previous close of ₹925.60, with intraday lows and highs ranging between ₹916.15 and ₹935.00. The stock remains comfortably above its 52-week low of ₹767.30 but still below its 52-week high of ₹1,105.00, indicating a moderate recovery phase within a broader trading range.

The daily moving averages have shifted to mildly bullish, reflecting a positive short-term trend. This is a significant development given the prior sideways movement, suggesting that buyers are gradually gaining control. The mild bullishness in moving averages aligns with the Bollinger Bands’ expansion, which often precedes stronger price moves.

Volume and On-Balance Volume (OBV) Insights

On-Balance Volume (OBV) remains mildly bearish on both weekly and monthly charts, indicating that volume trends have not yet confirmed the price gains. This divergence between price and volume suggests that while prices are rising modestly, the buying interest is not yet robust enough to signal a strong accumulation phase. Investors should watch for a potential OBV uptick to validate the emerging bullish momentum.

Dow Theory and Broader Market Context

According to Dow Theory, the weekly trend remains mildly bearish, but the monthly trend has turned mildly bullish. This divergence highlights a transitional phase where short-term caution coexists with longer-term optimism. The mixed signals from Dow Theory reinforce the need for investors to monitor upcoming price action closely before committing to a definitive stance.

Comparative Returns and Market Positioning

Fortis Healthcare’s returns have outperformed the Sensex over multiple time horizons, underscoring its relative strength within the hospital sector. Year-to-date, the stock has gained 5.82%, while the Sensex has declined by 7.35%. Over one year, Fortis has appreciated 9.01% compared to the Sensex’s 1.97% decline. The long-term returns are even more impressive, with a three-year gain of 176.26% versus the Sensex’s 20.14%, a five-year gain of 281.32% against 45.46%, and a ten-year gain of 395.89% compared to 181.19% for the benchmark index.

This strong relative performance highlights Fortis Healthcare’s resilience and growth potential, particularly as the hospital sector continues to benefit from increasing healthcare demand and infrastructure expansion.

Mojo Score and Rating Update

MarketsMOJO has upgraded Fortis Healthcare’s Mojo Grade from Sell to Hold as of 8 June 2026, reflecting the improved technical and fundamental outlook. The current Mojo Score stands at 60.0, placing the stock in a moderate position within the mid-cap hospital sector. This upgrade signals a cautious endorsement, suggesting that while the stock is not yet a strong buy, it has moved beyond the previous bearish sentiment.

Investors should note that the Hold rating implies a wait-and-watch approach, with potential for further upgrades if technical momentum strengthens and volume confirms price advances.

Outlook and Investor Considerations

Fortis Healthcare’s technical indicators collectively point to a mild bullish shift, but the presence of bearish signals in momentum and volume metrics advises prudence. The stock’s relative outperformance against the Sensex and its upgraded Mojo Grade provide a positive backdrop, yet the mixed technical signals suggest that investors should monitor key levels closely.

Key support lies near the 52-week low of ₹767.30, while resistance is expected near the 52-week high of ₹1,105.00. A sustained break above the moving averages and confirmation from MACD and OBV would strengthen the bullish case. Conversely, failure to hold current levels could see the stock revert to sideways or bearish trends.

Given the hospital sector’s growth prospects and Fortis Healthcare’s improving technical profile, the stock remains an interesting candidate for investors seeking exposure to healthcare infrastructure, albeit with a moderate risk appetite.

Summary

In summary, Fortis Healthcare Ltd is transitioning from a sideways technical trend to a mildly bullish phase, supported by daily moving averages and Bollinger Bands. Momentum indicators such as MACD and KST remain mildly bearish, while volume trends have yet to confirm the price gains. The stock’s relative outperformance versus the Sensex and an upgraded Mojo Grade to Hold reflect improving fundamentals and technicals. Investors should watch for confirmation signals in volume and momentum before increasing exposure, while recognising the stock’s long-term growth potential within the hospital sector.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today